Dasatinib and quercetin senolytic treatment delays early onset intervertebral disc degeneration in SM/J mice

Abstract

Genetic background is a major determinant of disc degeneration, a leading cause of chronic back pain and disability. Herein, we demonstrate that premature disc cell senescence contributes to early-onset degeneration in SM/J mice and test two systemic senotherapeutic strategies to mitigate it: Navitoclax (Nav.) and a cocktail of Dasatinib and Quercetin (DQ). While Nav. treatment did not improve severe degeneration in SM/J mice or senescence status, DQ-treated mice showed lower grades of degeneration and a decreased abundance of senescence markers, including p19ARF, p21, and the senescence-associated secretory phenotype (SASP). DQ improved disc cell viability and phenotype retention and retarded fibrosis of the nucleus pulposus tissue. Transcriptomic analysis revealed tissue-specific effects of the treatment, with cell cycle regulation and JNK signaling being commonly affected across different tissue types. A comparison of SM/J data with DQ-mediated aging-dependent amelioration of disc degeneration in C57BL/6 N mice identified Junb and Zfp36l1 signaling as shared DQ targets in the mouse disc. Notably, the in vitro inhibition studies of the JUN pathway in human degenerated NP cells mimicked the benefits of DQ, namely, a reduction in senescence and SASP. This study reinforces the efficacy of senolytic treatment in ameliorating local senescence and intervertebral disc fibrosis.

References

[1] Collaborators GBD 2017 Disease and Injury Incidence and Prevalence.. Global, regional, and national incidence, prevalence, and years lived with disability for 354 Diseases and Injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet, 2018, 392: P1789-P1858

[2] Teraguchi M, et al. . Prevalence and distribution of intervertebral disc degeneration over the entire spine in a population-based cohort: the Wakayama Spine Study. Osteoarthr. Cartil., 2014, 22: 104-110

[3] Shapiro, I. M. & Risbud, M. V. The Intervertebral Disc: Molecular and Structural Studies of the Disc in Health and Disease. https://doi.org/10.1007/978-3-7091-1535-0 (2002).

[4] Christ B, Huang R, Scaal M. Formation and differentiation of the avian sclerotome. Anat. Embryol. 2004 208:5, 2004, 208: 333-350

[5] Madhu V, et al. . The mitophagy receptor BNIP3 is critical for the regulation of metabolic homeostasis and mitochondrial function in the nucleus pulposus cells of the intervertebral disc. Autophagy, 2023, 19: 1821-1843

[6] Silagi ES, et al. . Lactate Efflux From Intervertebral Disc Cells Is Required for Maintenance of Spine Health. J. Bone Miner. Res., 2020, 35: 550-570

[7] Iatridis JC, Michalek AJ, Purmessur D, Korecki CL. Localized intervertebral disc injury leads to organ level changes in structure, cellularity, and biosynthesis. Cell Mol. Bioeng., 2009, 2: 437-447

[8] Ohnishi T, Novais EJ, Risbud MV. Alterations in ECM signature underscore multiple sub-phenotypes of intervertebral disc degeneration. Matrix Biol., 2020, 6–7: 100036

[9] Choi H, et al. . A novel mouse model of intervertebral disc degeneration shows altered cell fate and matrix homeostasis. Matrix Biol., 2018, 70: 102-122

[10] Novais EJ, Diekman BO, Shapiro IM, Risbud MV. p16 Ink4a deletion in cells of the intervertebral disc affects their matrix homeostasis and senescence associated secretory phenotype without altering onset of senescence. Matrix Biol., 2019, 82: 54-70

[11] Le Maitre, C. L., Freemont, A. J. & Hoyland, J. A. Accelerated cellular senescence in degenerate intervertebral discs: A possible role in the pathogenesis of intervertebral disc degeneration. Arthritis Res. Ther.9, R45 (2007).

[12] Novais EJ, et al. . Long-term treatment with senolytic drugs Dasatinib and Quercetin ameliorates age-dependent intervertebral disc degeneration in mice. Nat. Commun., 2021, 12 5213

[13] Battié MC, Videman T, Levälahti E, Gill K, Kaprio J. Genetic and environmental effects on disc degeneration by phenotype and spinal level: a multivariate twin study. Spine (Philos. Pa 1976), 2008, 33: 2801-2808

[14] Battié, M. C. et al. The Twin Spine Study: Contributions to a changing view of disc degeneration. Spine J. 9, 47–59 (2009).

[15] Annunen, S. et al. An allele of COL9A2 associated with intervertebral disc disease. Science.285, 409–412(1999).

[16] Takahashi, M. et al. The association of degeneration of the intervertebral disc with 5a/6a polymorphism in the promoter of the human matrix metalloproteinase-3 gene. J. Bone Joint Surg. - Series B83, 491–495 (2001).

[17] Huang, X. et al. Interleukin 6 (IL-6) and IL-10 promoter region polymorphisms are associated with risk of lumbar disc herniation in a northern chinese han population. Genet. Test Mol. Biomarkers21, 17–23 (2017).

[18] Toktaş, Z. O. et al. Association of collagen I, IX and vitamin D receptor gene polymorphisms with radiological severity of intervertebral disc degeneration in Southern European Ancestor. Eur. Spine J.24, 2432–2441(2015).

[19] Novais EJ, et al. . Comparison of inbred mouse strains shows diverse phenotypic outcomes of intervertebral disc aging. Aging Cell, 2020, 19 e13148

[20] Novais, E. J. et al. Neuroimmune changes underscore pain-associated behaviors and disc herniations in SM/J mice. bioRxivhttps://doi.org/10.1101/2024.02.23.581794 (2024).

[21] Zhang Y, et al. . Early onset of disc degeneration in SM/J mice is associated with changes in ion transport systems and fibrotic events. Matrix Biol., 2018, 70: 123-139

[22] Vo N, et al. . Accelerated Aging of Intervertebral Discs in a Mouse Model of Progeria. J. Orthop. Res, 2012, 100: 130-134

[23] REICH MS, JARVIS JP, SILVA MJ, CHEVERUD JM. Genetic relationships between obesity and osteoporosis in LGXSM recombinant inbred mice. Genet Res (Camb.), 2008, 90: 433-444

[24] Shingo H, Rai MF, Janiszak KL, Cheverud JM, Sandell LJ. Sandell Cartilage and Bone Changes during Development of Post- Traumatic Osteoarthritis in Selected LGXSM Recombinant Inbred Mice. Osteoarthr. Cartil., 2012, 20: 562-571

[25] Muñoz-espín D, Serrano M. Cellular senescence: from physiology to pathology. Nat. Rev. Mol. Cell Biol., 2014, 15: 482-496

[26] Zhu, Y. et al. New agents that target senescent cells: The flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463. Aging9, 955–963 (2017).

[27] Patil P, et al. . Systemic clearance of p16INK4a-positive senescent cells mitigates age-associated intervertebral disc degeneration. Aging Cell, 2019, 18 e12927

[28] Mannarino, M. et al. Senolytic treatment for low back pain. Sci. Adv.11, (2025).

[29] Cherif H, et al. . Senotherapeutic drugs for human intervertebral disc degeneration and low back pain. Elife, 2020, 9 e54693

[30] Ye N, Ding Y, Wild C, Shen Q, Zhou J. Small molecule inhibitors targeting activator protein 1 (AP-1). J. Med. Chem., 2014, 57: 6930-6948

[31] Yosef, R. et al. Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL. Nat. Commun.7, 11190 (2016).

[32] Leverson, J. D. et al. Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy. Sci. Transl. Med.7, 279ra40 (2015).

[33] Liao YR, Lin JY. Quercetin intraperitoneal administration ameliorates lipopolysaccharide-induced systemic inflammation in mice. Life Sci., 2015, 137: 89-97

[34] Hickson LTJ, et al. . Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease. EBioMedicine, 2019, 47: 446-456

[35] Justice JN, et al. . Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study. EBioMedicine, 2019, 40: 554-563

[36] Sao K, Risbud MV. Sdc4 deletion perturbs intervertebral disc matrix homeostasis and promotes early osteopenia in the aging mouse spine. Matrix Biol., 2024, 131: 46-61

[37] Tsingas M, et al. . Sox9 deletion causes severe intervertebral disc degeneration characterized by apoptosis, matrix remodeling, and compartment-specific transcriptomic changes. Matrix Biol., 2020, 94: 110-133

[38] Kim A, et al. . Inhibition of EphA2 by Dasatinib Suppresses Radiation-Induced Intestinal Injury. Int. J. Mol. Sci., 2020, 21: 9096

[39] Takasugi, M. et al. Small extracellular vesicles secreted from senescent cells promote cancer cell proliferation through EphA2. Nat. Commun.8, 15729 (2017).

[40] Saul D, et al. . A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues. Nat. Commun., 2022, 13: 1-15

[41] Thompson JP, et al. . Preliminary evaluation of a scheme for grading the gross morphology of the human intervertebral disc. Spine (Philos. Pa 1976), 1990, 15: 411-415

[42] Novais EJ, et al. . Long-term treatment with senolytic drugs Dasatinib and Quercetin ameliorates age-dependent intervertebral disc degeneration in mice. Nat. Commun., 2021, 12: 1-17

[43] Risbud MV, et al. . Nucleus pulposus cells express HIF-1α under normoxic culture conditions: A metabolic adaptation to the intervertebral disc microenvironment. J. Cell Biochem, 2006, 98: 152-159

[44] Levi N, Papismadov N, Solomonov I, Sagi I, Krizhanovsky V. The ECM path of senescence in aging: components and modifiers. FEBS J., 2020, 287: 2636-2646

[45] van der Kraan PM. The changing role of TGFβ in healthy, ageing and osteoarthritic joints. Nat. Rev. Rheumatol., 2017, 13: 155-163

[46] Tessier S, et al. . Arp2/3 inactivation causes intervertebral disc and cartilage degeneration with dysregulated TonEBP-mediated osmoadaptation. JCI Insight, 2020, 5 e131382

[47] Sanborn MA, Wang X, Gao S, Dai Y, Rehman J. Unveiling the cell-type-specific landscape of cellular senescence through single-cell transcriptomics using SenePy. Nat. Commun., 2025, 16 1884

[48] Vos, T. et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet386, 743–800 (2015).

[49] Makino H, et al. . A selective inhibition of c-Fos/activator protein-1 as a potential therapeutic target for intervertebral disc degeneration and associated pain. Sci. Rep., 2017, 7 16983

[50] Novais EJ, Diekman BO, Shapiro IM, Risbud MV. p16Ink4a deletion in cells of the intervertebral disc affects their matrix homeostasis and senescence associated secretory phenotype without altering onset of senescence. Matrix Biol., 2019, 82: 54-70

[51] Diekman BO, et al. . Expression of p16INK4ais a biomarker of chondrocyte aging but does not cause osteoarthritis. Aging Cell, 2018, 17 e12771

[52] Zhu Y, et al. . The achilles’ heel of senescent cells: From transcriptome to senolytic drugs. Aging Cell, 2015, 14: 644-658

[53] Sessions GA, et al. . Controlled induction and targeted elimination of p16INK4a-expressing chondrocytes in cartilage explant culture. FASEB J., 2019, 33: 12364-12373

[54] Lim, S. et al. Local delivery of senolytic drug inhibits intervertebral disc degeneration and restores intervertebral disc structure. Adv. Healthc. Mater.11, e2101483 (2022).

[55] Carragee EJ, et al. . 2009 ISSLS Prize Winner: does discography cause accelerated progression of degeneration changes in the lumbar disc. Spine (Philos. Pa 1976), 2009, 34: 2338-2345

[56] Paez-Ribes, M., González-Gualda, E., Doherty, G. J. & Muñoz-Espín, D. Targeting senescent cells in translational medicine. EMBO Mol. Med.11, e10234 (2019).

[57] Mohanty, S., Pinelli, R., Pricop, P., Albert, T. J. & Dahia, C. L. Chondrocyte-like nested cells in the aged intervertebral disc are late-stage nucleus pulposus cells. Aging Cell18, e13006 (2019).

[58] Beauséjour CM, et al. . Reversal of human cellular senescence: Roles of the p53 and p16 pathways. EMBO J., 2003, 22: 4212-4222

[59] Milanovic M, et al. . Senescence-associated reprogramming promotes cancer stemness. Nature, 2018, 553: 96-100

[60] Guo Q, et al. . STING promotes senescence, apoptosis, and extracellular matrix degradation in osteoarthritis via the NF-κB signaling pathway. Cell Death Dis. 2021 12:1, 2021, 12: 1-14

[61] Kang C. Senolytics and Senostatics: A Two-Pronged Approach to Target Cellular Senescence for Delaying Aging and Age-Related Diseases. Mol. Cells, 2019, 42: 821-827

[62] Ottone OK, Kim C, Collins JA, Risbud MV. The cGAS-STING Pathway Affects Vertebral Bone but Does Not Promote Intervertebral Disc Cell Senescence or Degeneration. Front Immunol., 2022, 13: 882407

[63] Burt, K. G., Kim, M. K. M., Viola, D. C., Abraham, A. C. & Chahine, N. O. Nuclear factor κB overactivation in the intervertebral disc leads to macrophage recruitment and severe disc degeneration. Sci. Adv.10, eadj3194 (2024).

[64] Mathas S. Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappaB. EMBO J., 2002, 21: 4104-4113

[65] Spallarossa P, et al. . p38 MAPK and JNK Antagonistically Control Senescence and Cytoplasmic p16INK4A Expression in Doxorubicin-Treated Endothelial Progenitor Cells. PLoS One, 2010, 5: e15583

[66] Sundqvist A, et al. . JUNB governs a feed-forward network of TGFβ signaling that aggravates breast cancer invasion. Nucleic Acids Res, 2018, 46: 1180-1195

[67] Cui L, et al. . Activation of JUN in fibroblasts promotes pro-fibrotic programme and modulates protective immunity. Nat. Commun., 2020, 11 2795

[68] Choi KS, Harfe BD. Hedgehog signaling is required for formation of the notochord sheath and patterning of nuclei pulposi within the intervertebral discs. Proc. Natl. Acad. Sci. USA, 2011, 108: 9484-9489

[69] Maeda Y, et al. . Indian Hedgehog produced by postnatal chondrocytes is essential for maintaining a growth plate and trabecular bone. Proc. Natl. Acad. Sci. USA, 2007, 104: 6382-6387

[70] Schindelin, J. et al. Fiji: An open-source platform for biological-image analysis. Nat. Methods. 9, 676–682 (2012).

[71] Mi H, et al. . Protocol Update for large-scale genome and gene function analysis with the PANTHER classification system (v.14.0). Nat. Protoc., 2019, 14: 703-721

[72] Huang X, Chen C, Chen Y, Xu J, Liu L. Omentin-1 alleviate interleukin-1β(IL-1β)-induced nucleus pulposus cells senescence. Bioengineered, 2022, 13: 13849-13859

[73] Purohit A, Singh A, Ghilchik MW, Serlupi-Crescenzi O, Reed MJ. Inhibition of IL-6 + IL-6 soluble receptor-stimulated aromatase activity by the IL-6 antagonist, Sant 7, in breast tissue-derived fibroblasts. Br. J. Cancer, 2003, 88: 630-635

[74] Qiu Y, et al. . Combination of dasatinib and quercetin promotes osteogenic differentiation and stemness maintenance of hPDLSCs via YAP/TAZ. Anim. Cells Syst. (Seoul.), 2025, 29: 201-211

[75] Gadecka A, et al. . The senolytic cocktail, dasatinib and quercetin, impacts the chromatin structure of both young and senescent vascular smooth muscle cells. Geroscience, 2025, 47: 3907-3925

[76] Aikawa Y, et al. . Treatment of arthritis with a selective inhibitor of c-Fos/activator protein-1. Nat. Biotechnol., 2008, 26: 817-823

Funding

U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(R01AR055655)

Fundação para a Ciência e a Tecnologia (FCT) - University of Minho

RIGHTS & PERMISSIONS

The Author(s)